triazoles has been researched along with Hepatic Veno Occlusive Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cangemi, G; Castagnola, E; Dufour, C; Mesini, A; Palmisani, E | 1 |
| Cho, EJ; Chueh, HW; Kim, JY; Koo, HH; Lee, SH; Sung, KW; Yoo, KH | 1 |
1 trial(s) available for triazoles and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Iron chelation treatment with deferasirox prior to high-dose chemotherapy and autologous stem cell transplantation may reduce the risk of hepatic veno-occlusive disease in children with high-risk solid tumors.
Topics: Acute Kidney Injury; Benzoates; Brain Neoplasms; Child; Child, Preschool; Deferasirox; Erythrocyte Transfusion; Fanconi Syndrome; Female; Ferritins; Hepatic Veno-Occlusive Disease; Humans; Induction Chemotherapy; Infant; Iron Chelating Agents; Male; Neuroblastoma; Stem Cell Transplantation; Transplantation, Autologous; Triazoles | 2012 |
1 other study(ies) available for triazoles and Hepatic Veno Occlusive Disease
| Article | Year |
|---|---|
Hepatic veno-occlusive disease during isavuconazole administration.
Topics: Antifungal Agents; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Nitriles; Pyridines; Triazoles; Young Adult | 2018 |